Indianapolis-based drugmaker Eli Lilly and Company has announced price reductions ... effective as of Q4 2023. Both Humalog and Insulin Lispro Injection are fast-acting insulins, they are used ...

Eli Lilly continues to see strong growth coming from its GLP-1 drugs. The company's current 2025 guidance looks conservative.

1,2 The Egyptian Drug Authority approved the insulin glargine injection manufactured by EVA Pharma through a collaboration with Eli Lilly and Company (NYSE: LLY). Launched in 2022, the ...

The 'big three' insulin producers Novo Nordisk ... Novo Nordisk's Novolog, and Lilly's Humalog – by 2024. The company said its products will cost no more than $30 per vial or $55 for five ...

Eli Lilly strengthens its pipeline with AdvanCell for targeted alpha therapies and partners with OliX to advance OLX75016 for ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other dividend growth stocks. Dividend stocks faced a tough year in 2024 as investor focus ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on UnitedHealth (UNH – Research Report) and Eli ...